Combined with the SHAP analysis results, it is evident that PSMA PET/CT-derived parameters such as PSMA-TVp and TL-PSMAp play a dominant role in predicting prostate cancer metastasis, outperforming the traditional SUVmax metric. The gene discussed is FOLH1; the disease is Familial prostate cancer.